Structural Insights into Molecular Recognition and Receptor Activation in Chemokine–Chemokine Receptor Complexes
L Urvas, E Kellenberger - Journal of Medicinal Chemistry, 2023 - ACS Publications
The chemokine system is a key player in the functioning of the immune system and a sought-
after target for drug candidates. The number of experimental structures of chemokines in …
after target for drug candidates. The number of experimental structures of chemokines in …
Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins
The complement receptors C3aR and C5aR1, whose signaling is selectively activated by
anaphylatoxins C3a and C5a, are important regulators of both innate and adaptive immune …
anaphylatoxins C3a and C5a, are important regulators of both innate and adaptive immune …
[HTML][HTML] Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Glioblastoma (GBM) is the most aggressive tumor in the central nervous system and
contains a highly immunosuppressive tumor microenvironment (TME). Tumor-associated …
contains a highly immunosuppressive tumor microenvironment (TME). Tumor-associated …
[HTML][HTML] Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
The CC motif chemokine receptor 8 (CCR8) is a class A G-protein coupled receptor that has
emerged as a promising therapeutic target in cancer. Targeting CCR8 with an antibody has …
emerged as a promising therapeutic target in cancer. Targeting CCR8 with an antibody has …
Cholesterol biases the conformational landscape of the chemokine receptor CCR3: A MAS SSNMR-filtered molecular dynamics study
EJ Van Aalst, CJ McDonald… - Journal of Chemical …, 2023 - ACS Publications
Cholesterol directs the pathway of ligand-induced G protein-coupled receptor (GPCR) signal
transduction. The GPCR C–C motif chemokine receptor 3 (CCR3) is the principal …
transduction. The GPCR C–C motif chemokine receptor 3 (CCR3) is the principal …
Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8
S Jiang, X Lin, L Wu, L Wang, Y Wu, Z Xu, F Xu - Science Advances, 2024 - science.org
The human CC chemokine receptor 8 (CCR8) is an emerging therapeutic target for cancer
immunotherapy and autoimmune diseases. Understanding the molecular recognition of …
immunotherapy and autoimmune diseases. Understanding the molecular recognition of …
[HTML][HTML] Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2
X Pan, F Ye, P Ning, Z Zhang, X Li, B Zhang, Q Wang… - Cell Discovery, 2023 - nature.com
Abstract Hydroxycarboxylic acid receptor 2 (HCAR2) belongs to the family of class AG
protein-coupled receptors with key roles in regulating lipolysis and free fatty acid formation …
protein-coupled receptors with key roles in regulating lipolysis and free fatty acid formation …
[HTML][HTML] Differential expression of innate and adaptive immune genes during acute physical exercise in American quarter horses
J Wilson, M De Donato, B Appelbaum, CT Garcia… - Animals, 2023 - mdpi.com
Simple Summary Overtraining syndrome (OTS) is the reduction in performance due to
excess training and lack of proper recovery, which can lead to the chronic deprivation of …
excess training and lack of proper recovery, which can lead to the chronic deprivation of …
[HTML][HTML] Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism
LS den Hollander, OJM Béquignon, X Wang… - Biochemical …, 2023 - Elsevier
Abstract CC chemokine receptor 2 (CCR2), a G protein-coupled receptor, plays a role in
many cancer-related processes such as metastasis formation and immunosuppression …
many cancer-related processes such as metastasis formation and immunosuppression …
[HTML][HTML] Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells
KK Parwani, GM Branella, RE Burnham… - Frontiers in …, 2024 - frontiersin.org
Vγ9Vδ2 T cells represent a promising cancer therapy platform because the implementation
of allogenic, off-the-shelf product candidates is possible. However, intravenous …
of allogenic, off-the-shelf product candidates is possible. However, intravenous …